Bntx stocks.

J.P. Morgan's assessment implies potential challenges for in keeping up with performance expectations compared to its broader coverage group. Price Action: BNTX shares are down 2.13% at $98.27 on ...A relevant player like HCSG may thus be one of the undervalued stocks that analysts love. On paper, shares trade at a forward earnings multiple of 14.39x, lower than the sector median of 21.89x ...BioNTech SE ADR historical stock charts and prices, analyst ratings, financials, and today’s real-time BNTX stock price. ... BioNTech SE ADR BNTX (U.S.: Nasdaq) search. View All companies. 1:00 ...CEO. Website. 2008. 5,700. Ugur Sahin. https://www.biontech.de. BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is …

Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing. BNTX stock currently hovers slightly below $170, up 45% over the past 12 months. The stock price has declined 24.5% YTD. Shares are trading at 4.9 times forward earnings and 2.5 times trailing sales.

Discover historical prices for BNTX stock on Yahoo Finance. View daily, weekly or monthly format back to when BioNTech SE stock was issued.16 Oct 2023 ... Topline. Stocks of Pfizer and other Covid vaccine makers like BioNTech and Moderna fell in premarket trading Monday after the company slashed ...

3. BioNTech. Per its coronavirus vaccine collaboration with Pfizer, BioNTech ( BNTX 1.40%) is the only company on this list that's currently earning revenue as a result of its sales of mRNA ...In Q3, BioNTech reported total revenues of €895.3m, all derived from COVID vaccine sales, a net profit of €161m, and diluted earnings per share ("EPS") of $0.67. Across the first nine months ...BioNTech SE (NASDAQ:BNTX) posted its quarterly earnings results on Monday, November, 6th. The company reported $0.67 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.59) by $1.26. The firm had revenue of $895.30 million for the quarter, compared to analysts' expectations of $850.50 million.BNTX stock analysts forecast roughly 16 billion euros in sales. Still, much of the outlook will depend on booster demand. Less than 10% of adults in the U.S. have gotten an updated booster shot ...

BioNTech stock has underperformed the broader markets over the past year and is down more than 29%. However, analysts’ average 12-month price target of $151 implies 33.37% upside potential from current levels. Wall Street analysts remain cautiously optimistic about BNTX stock due to the uncertainty around COVID-19 vaccine demand …

3 Nov 2022 ... Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social ...

Plenty of stocks have been left behind and many carry outsize yields of 6% or more—including a total of about 40 in the S&P 500 and S&P MidCap 400 indexes, according to data from S&P Dow Jones ...Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.BNTX Stock Assessment. Per Seeking Alpha, BioNTech's stock assessment reveals a mixed bag of results. In terms of valuation, the company is rated "A+" with forward-looking non-GAAP P/E at 20.76 ...Jun 2, 2023 · What happened. Shares of BioNTech ( BNTX 3.25%) were up as by much as 5.3% on Friday before closing the session up 3.85% after the biotech company announced positive news regarding a clinical ... BioNTech (NASDAQ: BNTX), a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock rally from about $80 at the end of 2020 to levels of almost $420 currently ...Nov 6, 2023 · BNTX stock analysts expected 4.44 billion euros in sales for the year. Germany-based BioNTech noted fewer people are receiving primary vaccinations and population-wide boosting is much lower. Dec 1, 2023 · BNTX Earnings Date and Information. BioNTech last issued its quarterly earnings results on November 6th, 2023. The reported $0.67 earnings per share for the quarter, topping the consensus estimate of ($0.59) by $1.26. The business earned $895.30 million during the quarter, compared to analyst estimates of $850.50 million.

When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll want to ensure that you find the best one available in stock.The share price of BioNTech SE (BNTX) now. What analysts predict: $142.42. 52-week High/Low: $188.99 / $88. 50/200 Day Moving Average: $101.74 / $113.19. This figure corresponds to the Average Price over the previous 50/200 days. For BioNTech stocks, the 50-day moving average is the resistance level today.Apple Inc. Common Stock. $179.24 -0.12 -0.07%. Find the latest Earnings Report Date for BioNTech SE American Depositary Share (BNTX) at Nasdaq.com.Find the latest BioNTech SE (BNTX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Some of the best international stocks to buy now include Alibaba Group Holding Limited (NYSE: BABA ), Nutrien Ltd. (NYSE: NTR ), and Unilever PLC (NYSE: UL ).2 days ago

Is BioNTech Stock a Buy Now? Nasdaq , BioNTech Looks to Expand into Other Markets as COVID-19 Revenues Dwindle BioSpace , Moderna, BioNTech Lose $60 Billion ...

BioNTech SE ADR analyst ratings, historical stock prices, earnings estimates & actuals. BNTX updated stock price target summary. BNTX : 98.83 (+0.89%) SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioNTech SE - BNTX PR Newswire - Tue Oct 17, 7:35PM CDT. /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of BioNTech SE ("BioNTech" or the "Company") (NASDAQ: BNTX).BioNTech SE ADR historical stock charts and prices, analyst ratings, financials, and today’s real-time BNTX stock price. ... BioNTech SE ADR BNTX (U.S.: Nasdaq) search. View All companies. 1:00 ... The latest BioNTech stock prices, stock quotes, news, and BNTX history to help you invest and trade smarter. ... BioNTech Stock Snapshot. 173.78 Bid. 100.00 Bid Size ...The company's average rating score is 2.30, and is based on 4 buy ratings, 5 hold ratings, and 1 sell rating. Price Target Upside/Downside. According to ...21 Jun 2023 ... BNTX is more profitable, with a gross profit margin and net income margin of 85.29% and 51.08%, respectively, compared to MRNA's 39.82% and ...Like many other biotech names, BNTX stock has fallen 30 % YTD. Shares are trading at 4.2 times forward earnings and only 1.7 times sales. At present, the 12-month median price forecast for ...Get the latest BioNTech SE (BNTX) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.See the company profile for BioNTech SE (BNTX) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ...

Aug 7, 2023 · BNTX stock analysts projected a per-share loss of 30 cents. BioNTech blamed write-offs to partner Pfizer for the profit and sales hits. On today's stock market, BNTX stock toppled 7.5% to 98.50 ...

Jun 18, 2023 · BNTX Stock Assessment. Per Seeking Alpha, BioNTech's stock assessment reveals a mixed bag of results. In terms of valuation, the company is rated "A+" with forward-looking non-GAAP P/E at 20.76 ...

About BioNTech SE ADR BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac,...BioNTech (NASDAQ: BNTX), a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock rally from about $80 at the end of 2020 to levels of almost $420 currently ...BioNTech SE ADR historical stock charts and prices, analyst ratings, financials, and today’s real-time BNTX stock price. ... BioNTech SE ADR BNTX (U.S.: Nasdaq) search. View All companies. 1:00 ... However, it's significantly underperforming BNTX stock's YTD return of 258.1%. What was Moderna's FY22 Outlook Presented in FQ3? Moderna presented a reasonably strong FY22 guidance in its FQ3 ...BioNTech SE (BNTX) will release its next earnings report on Mar 20, 2024. In the last quarter BioNTech SE reported -$0.631 EPS in relation to $0.716 expected by the market.Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing. BioNTech SE ADR historical stock charts and prices, analyst ratings, financials, and today’s real-time BNTX stock price. ... BioNTech SE ADR BNTX (U.S.: Nasdaq) search. View All companies. 1:00 ...Additionally, the market prices BNTX at a forward multiple of 20.52. As a discount to projected earnings, BioNTech ranks better than 66.67% of companies listed in the biotech space. Thus, forward ...Over the past 3 months, 15 analysts have published their opinion on BioNTech (NASDAQ:BNTX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a ...

BioNTech BioNTech SE (BNTX) NASDAQ 97.16 -1.67 (-1.69%) 02:30:00 Close USD Disclaimer After-Hours 96.00 -1.16 (-1.19%) 6:27:36 GMT Overview Profile Chart News & Analysis Technical Financials...BioNTech (NASDAQ:BNTX – Get Free Report) was downgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “underweight” rating in a research note issued to investors on Friday, Marketbeat.com reports.They currently have a $99.00 target price on the stock, down from their previous target price of $106.00. JPMorgan …Aug 7, 2023 · BNTX stock analysts projected a per-share loss of 30 cents. BioNTech blamed write-offs to partner Pfizer for the profit and sales hits. On today's stock market, BNTX stock toppled 7.5% to 98.50 ... View the latest BioNTech SE ADR (BNTX) stock price, news, historical charts, analyst ratings and financial information from WSJ.Instagram:https://instagram. dfas stockbest bank stocksfidelity freedom 2035tflr J.P. Morgan's assessment implies potential challenges for in keeping up with performance expectations compared to its broader coverage group. Price Action: BNTX shares are down 2.13% at $98.27 on ... best dave ramsey book to start withtriple a renters insurance How we approach editorial content. See the latest BioNTech SE ADR stock price (BNTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions. ai nsfw bot What this means: InvestorsObserver gives Biontech Se ADR (BNTX) an overall rank of 31, which is below average. Biontech Se ADR is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 31 means that 69% of stocks appear more favorable to our system.Based on analysts offering 12 month price targets for BNTX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .